The MIM Society Award: Celebrating Excellence
The MIM Society recognizes the outstanding contributions of malaria researchers and individuals who have played a pivotal role in the global fight against malaria. Their unwavering dedication and expertise are critical in combatting this deadly disease worldwide.
The MIM Society Awards are established in honor of eminent malaria scientists, researchers, and public health advocates: Prof. Ogobara Doumbo, Dr. Brian Sharp, and Dr. Peter J. de Vries.
Ogobara Doumbo MIM Award for Lifetime Achievements in Malaria Research and Capacity Building
The MIM Society presents the “Ogobara Doumbo MIM Award for Lifetime Achievements in Malaria Research and Capacity Building” to the following distinguished individuals:
Prof. Marita Troye Blomberg
Professor Emeritus of Molecular
Biosciences, Department of Molecular
Biosciences, The Wenner-Gren Institute,
Stockholm, Sweden
Prof. Oumar Gaye
Malaria Research and Capacity Development
(MARCAD), Université Cheikh Anta Diop,
Dakar, Senegal
Prof. Dyann F. Wirth
Richard Pearson Strong Professor of
Infectious Diseases Immunology and
Infectious Diseases, Harvard Chan School of
Public Health.
Prof. Pedro Alonso
Global Health Faculty of Medicine and
Health Science, Hospital Clinic, University
of Barcelona.
Prof. Wen Kilama
Retired Professor of Parasitology, African
Malaria Network Trust (AMANET)
Prof. Kevin Marsh
Malarialogy and Global Health, Oxford
University/KEMRI, Kenya
Prof. Marcel Tarner
Epidemiology and Medical Parasitology,
University of Basel, Switzerland
Prof. Ayoade MJ Oduola
Molecular Pharmacology & Parasitology, West
Africa Institute for Research on Infectious
Diseases of Poverty, Nigeria.
Prof. Fred Newton Binka
Distinguished Professor of Clinical
Epidemiology, University of Health and
Allied Sciences (UHAS), Ghana
Prof. Gilbert Kokwaro
Professor of Health Systems Research and
Director, Institute of Healthcare
Management, Strathmore University Business
School, Kenya
Dr. Halima Mwenesi
Capacity Development and Global Health,
Consultant, USA
Prof. Louis Miller
Infectious Diseases Epidemiologist,
National Institute Allergy and Infectious
Diseases, NIH, USA
Prof. Olumide Ogundahunsi
Director Strategy & Program Management
Development, Prof of Pharmacology, Ondo
State, University of Medical Science,
Nigeria
Prof. Andrew Kitua
Deputy Vice-Chancellor, Research,
Innovation, Consultancy & Extension,
Tanzania
Prof. Bernhard Ogutu
Director of the Centre for Research in
Therapeutic Sciences (CREATES), Strathmore
University, Kenya
Prof. Rajendra Maharaj
Director Office of Malaria Research, South
African Medical Research Council, Republic
of South Africa
Brian Sharp Young Investigators Award
The MIM Society is proud to present the “Brian Sharp Young Investigators Award” to recognize excellence in oral presentations at 8th Pan-African Malaria Conference. This award is given to the following 20 outstanding researchers:
Best Oral Presenters
| Presenter | Abstract Number | Track | Title |
|---|---|---|---|
| John Mwangi | 351 | Bioethics and Diversity | Empowering Young Changemakers - The Kenya Malaria Youth Corps and the Fight Against Malaria in Africa |
| Pierre Gashema | 324 | Capacity Building | Malaria Microscopy Quality Control in Rwanda: Data Spanning Seven Years (2017-2023) |
| Ngo Bibaa Lundi-Anne Omam | 212 | Chemoprevention | Advancing Malaria Elimination with a digitized approach: the case of Seasonal Malaria Chemoprevention 2023 in Benin |
| Mavuto Mukaka | 164 | Control and Elimination | Pharmacokinetics of single low dose primaquine to support malaria elimination in Ugandan and Congolese children with acute falciparum malaria |
| David Jolly Muganzi | 400 | Diagnosis and Reagent | Advancing light microscopic malaria diagnosis with machine learning. |
| Noella Umulisa | 361 | Drug Efficacy | Efficacy of dihydro-artemisinin piperaquine for the treatment of uncomplicated plasmodium falciparum infection in Rwanda, 2023 |
| Sachel Mok | 329 | Drug Resistance | Mapping the genetic landscape of multidrug resistance in Plasmodium falciparum by leveraging genetic crosses in a humanized mouse model |
| Dr Angela Minassian | 63 | Immunology & Vaccines | RH5.1/Matrix Results of an efficacy trial against clinical P. falciparum malaria in 5-17 month old infants in a Phase IIb randomised trial in Burkina Faso |
| Arthur Sovi | 278 | Implementation Science and Health Systems | The impact of next-generation dual-active ingredient long-lasting insecticidal net deployment on insecticide resistance in malaria vectors: results of a three-year cluster-randomized controlled trial in Benin |
| Magellan Tchouakui | 82 | Insecticide Resistance | The duplicated P450s, CYP6P9a and CYP6P9b proficient pyrethroid metabolizers, are reducing neonicotinoid efficacy in Anopheles funestus while exacerbating the potency of Chlorfenapyr |
| Flavia Camponovo | 131 | Malaria Epidemiology | Increasing case management coverage reduces malaria prevalence across endemic settings |
| Oliver Watson | 132 | Malaria Epidemiology | Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa |
| Jaishree Raman | 206 | Malaria Genomics | Unravelling Plasmodium falciparum genetic diversity using targeted amplicon deep sequencing to guide elimination interventions in South Africa |
| Sequoia Leuba | 126 | Malaria in Pregnancy | Quantifying the impact of malaria in pregnancy on maternal anaemia and its associated burden across Africa |
| Michael Lintner Rivera | 273 | Parasite & Systems Biology | Perfusion Index as an Indicator for Mortality in Children with Plasmodium falciparum Severe Malaria |
| Andrea L Conroy | 113 | Pathogenesis and Co-Morbidities | Elevated ferritin, severe malaria, and acute kidney injury |
| Nekoye Otsyula | 170 | Phytomedicines and Pharmacology | Introducing a Phase 3 of KLU156, a non-artemisinin combination, compared to Coartemå¨ (artemether-lumefantrine) for efficacy and safety in uncomplicated P. falciparum malaria |
| Carol Kamya | 29 | Social and Health Economics | Cost-Effectiveness of weekly Dihydroartemisinin-Piperaquine versus Sulphadoxine-Pyrimethamine for Malaria Chemoprevention in Children with Sickle Cell Anemia: A Comparative Analysis in Uganda and Malawi |
| Benson Mringo | 196 | Treatment and Case Management | Leveraging Village Health Nutrition Day Plus to improve coverage of malaria services amongst children under five in Tanzania: A case study of Kibuye & Kibingo villages. |
| Doreen Siria | 50 | Vector Biology and Control | Rapid age-grading and species identification of natural mosquitoes for malaria surveillance |
Peter J. de Vries Young Investigators Award
The MIM Society is pleased to present the “Peter J. de Vries Young Investigators Award” in recognition of the best poster presentations at the MIM Society 8th Pan- African Malaria Conference. The following 17 researchers have demonstrated exceptional work:
Best Poster Presenters
| Presenter | Thematic Area | Title |
|---|---|---|
| Deogratias Ndagijimana | Malaria Epidemiology, Modelling, Surveillance and Impact | Mapping malaria hotspots among high-risk groups in Rwanda: An opportunity for targeted interventions |
| Timo Reib | Immunology & Vaccines (Children, Pregnant Women and Adults) | How FHR-1 deficiency affects the infection with the malaria pathogen Plasmodium falciparum |
| Elisabet Martí Coma-Cros | Control, Elimination and Eradication | MESA Track - the unique free and open-access database of malaria projects |
| Linda Eva Amoah | Diagnosis and Reagents Development | AQ Malaria, a saliva-based method for malaria diagnosis |
| Moussa DJIMDE | Malaria in Pregnancy | Neutropenia and its possible effect on the effectiveness of artemisinin-based combination therapy in pregnant women in Mali |
| Samuel Kweku Dadzie | Insecticide Resistance | Malaria vector surveillance across 30 sentinel sites for informed decision making towards malaria elimination in Ghana |
| William Stone | Drug Efficacy | The transmission reducing activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: a synthesis of novel trials from 2019-2023 |
| Faustinah Sakari | Treatment and Community Case Management | Trends of adherence to malaria testing and treatment guidelines by community health volunteers in Kakamega county, Kenya. |
| Kwabena Owusu-Kyei | Chemoprevention | Assessment of Intermittent Preventive Treatment with Sulfadoxine Pyrimethamine coverage and the Relationship between Anaemia and Malaria Infections among Young Children in Northern Sierra Leone: A Prospective Cohort Study |
| Ganiyat Eshikhena | Capacity Building, Leadership, and Governance | Strengthening Local Capacity for Mathematical Modelling in Public Health Professionals in LMICs: Lessons learnt |
| Moustapha Nikiema | Drug Resistance | Monitoring antimalarial drug resistance markers using Anopheles mosquitoes in Burkina Faso |
| Jessie Hamon | Implementation Science and Health systems | How, why, and under what circumstances do supportive supervision programs improve malaria case management? |
| Martin Kampmann | Parasite and Systems Biology | Transcriptional and genomic signatures associated with continuous P. falciparum asexual replication and asymptomatic persistence. |
| George Awungafac | Pathogenesis and Co-morbidities (Including Parasite & Systems Biology) | Risk of malaria in type 2 diabetes with or without metabolic syndrome in Cameroon: Baseline results from a prospective cohort |
| Matthew Higgins | Malaria Genomics (Human-Anopheles-Plasmodium) | New reference genomes for neglected Plasmodium ovale curtisi and Plasmodium ovale wallikeri |
| George Adu Asumah | Vector Biology and Control | Barriers and Facilitators of Insecticide Treated Nets in Ghana: A Systematic Review of Available Evidence, 2022 |
| Charlotte Kern | Phytomedicines, Pharmacology and Drug Development | Using dried blood spot sampling for ivermectin population pharmacokinetics modeling during a mass drug administration campaign in Mozambique |